TALVEY®
(talquetamab-tgvs)
TALVEY® (talquetamab-tgvs)
TALVEY - Pivotal clinical trial publications
MonumenTAL-1 (MMY1001)
Chari A, Minnema MC, Berdeja JG, et al. Talquetamab, a T-cell-redirecting GPRC5D bispecific antibody for multiple myeloma. N Engl J Med. 2022;387(24):2232-2244.